aTyr Pharma

Biotechnology Research • San Diego, California, United States • 51-100 Employees

Company overview

Headquarters	10240 Sorrento Valley Rd, Suite 300, San Diego, California 92121, US
Phone number	+18587318389
Website	atyrpharma.com
NAICS	541714
SIC	873
Keywords	Biologics, Autoimmune Diseases, Drug Discovery And Development, Rare And Orphan Diseases
Employees	51-100
Socials

Key Contacts at aTyr Pharma

Jackie Yan Yichuan

Director Corporate Development

Grace Tao

Director Of Medical Affairs

Ashlee Dunston

Director, Investor Relations And Public Affairs

Eileen Sun

Executive Director, Product Development

Benjamin Barnhill

Associate Director - Analytical/Formulation

Armando Dequesada

Associate Director, Supply Chain

Cory Soto

Director

Ryan Adams

Senior Director - In Vitro Biology

David Rustum

Senior Director Of Marketing

Christoph Burkart

Director

aTyr Pharma Email Formats

aTyr Pharma uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@atyrpharma.com), used 63.8% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@atyrpharma.com	63.8%
{first name}{last name}	johndoe@atyrpharma.com	31%
{last name}{last name}	doedoe@atyrpharma.com	3.4%
{first initial}	j@atyrpharma.com	1.7%

About aTyr Pharma

aTyr Pharma (Nasdaq: LIFE) is a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel biological pathways. aTyr’s research and development efforts are concentrated on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. aTyr has built a global intellectual property estate directed to a potential pipeline of protein compositions derived from 20 tRNA synthetase genes and their extracellular targets. aTyr’s primary focus is efzofitimod (ATYR1923), a clinical-stage product candidate which binds to the neuropilin-2 receptor and is designed to down-regulate immune engagement in severe inflammatory lung diseases. For more information, please visit http://www.atyrpharma.com. The Company was founded by Professors Paul Schimmel, Ph.D., and Xiang-Lei Yang, Ph.D., two leading aminoacyl tRNA synthetase scientists at The Scripps Research Institute.

aTyr Pharma revenue & valuation

Annual revenue	$235,000
Revenue per employee	$3,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$752,000
Total funding	$80,700,000